Live Cell Imaging Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Live Cell Imaging Market covers analysis By Product ( Equipment, Kits and Reagents, Software, Consumables ); Technology ( Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High-content Analysis, Fluorescence In Situ Hybridization, Others ); Application ( Drug Discovery, Cell Biology, Developmental Biology, Stem Cells, Others ); End User ( Pharmaceutical and Biotechnology Companies, Hospitals, Diagnostic Laboratories, Others ) and geography , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPHE100001215
  • Category : Biotechnology
  • No. of Pages : 150

Live Cell Imaging Market Key Findings by 2031

Buy Now

MARKET OVERVIEW

Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. This method is used by the scientists to obtain a better view of the cell's biological function by studying the cellular dynamics. In recent years, live cell imaging technology has been widely accepted by various researchers to obtain a better knowledge regarding cell biology. Live cell imaging plays a crucial role in research fields such as neurology, immunology, microbiology and, genetics among others.

MARKET SCOPE

The "Global Live Cell Imaging Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the live cell imaging market with detailed market segmentation by product, technology, application, end user, and geography. The report provides key statistics on the market status of the leading live cell imaging market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on product, the global live cell imaging market is segmented into equipment, kits and reagents, software, consumables.
  • On the basis of technology, the market is segmented into fluorescence recovery after photobleaching, fluorescence resonance energy transfer, high-content analysis, fluorescence in situ hybridization, and others.
  • Based on application, the market is bifurcated into Drug Discovery, Cell Biology, Developmental Biology,, Stem Cells, Others.
  • Based on end user, the market is segmented into pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and others.

MARKET DYNAMICS

Drivers

  • Rising number of government funds for research and development activities.
  • Increasing number of cancer cases worldwide
  • Increasing adoption of biotechnology-based personalized medicine.

Restraints-

  • Under-developed research sector in a few developing countries

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The live cell imaging market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the live cell imaging market in these regions.

IMPACT OF COVID-19 ON LIVE CELL IMAGING MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

Live Cell Imaging Market Report Analysis

Live Cell Imaging Market
  • CAGR
    CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc
  • General Electric
  • Olympus Corporation
  • BioTek Instruments Inc
  • Molecular Devices LLC
  • CYTOSKELETON INC
  • Bruker
  • Nikon Instruments Inc

Regional Overview

Regional Overview
  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

Market Segment By Product
  • Equipment
  • Kits and Reagents
  • Software
  • Consumables
Market Segment By Technology
  • Fluorescence Recovery After Photobleaching
  • Fluorescence Resonance Energy Transfer
  • High-content Analysis
  • Fluorescence In Situ Hybridization
Market Segment By Application
  • Drug Discovery
  • Cell Biology
  • Developmental Biology
  • Stem Cells
Market Segment By End User
  • Pharmaceutical and Biotechnology Companies
  • Hospitals
  • Diagnostic Laboratories
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS

The report covers key developments in the live cell imaging market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from live cell imaging market are anticipated to lucrative growth opportunities in the future with the rising demand for live cell imaging in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the live cell imaging market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • General Electric
  • Olympus Corporation
  • BioTek Instruments, Inc.
  • Molecular Devices, LLC.
  • CYTOSKELETON, INC.
  • Bruker
  • Nikon Instruments Inc.
  • Merck KGaA

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Live Cell Imaging Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Equipment
  • Kits and Reagents
  • Software
  • Consumables
By Technology
  • Fluorescence Recovery After Photobleaching
  • Fluorescence Resonance Energy Transfer
  • High-content Analysis
  • Fluorescence In Situ Hybridization
By Application
  • Drug Discovery
  • Cell Biology
  • Developmental Biology
  • Stem Cells
By End User
  • Pharmaceutical and Biotechnology Companies
  • Hospitals
  • Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • PerkinElmer Inc
  • General Electric
  • Olympus Corporation
  • BioTek Instruments Inc
  • Molecular Devices LLC
  • CYTOSKELETON INC
  • Bruker
  • Nikon Instruments Inc
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage

Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered

Segment Covered

This text is related
to segments covered.

Regional Scope

Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope

Country Scope

This text is related
to country scope.

The List of Companies

1. Thermo Fisher Scientific Inc.
2. PerkinElmer Inc.
3. General Electric
4. Olympus Corporation
5. BioTek Instruments, Inc.
6. Molecular Devices, LLC.
7. CYTOSKELETON, INC.
8. Bruker
9. Nikon Instruments Inc.
10. Merck KGaA
11. Keyence Corporation
12. NanoLive SA
13. Sony Biotechnology Inc.
14. Phase Focus
15. Logos Biosystems (Aligned Genetics, Inc.)

Trends and growth analysis reports related to Biotechnology : READ MORE..